Revolutions Medical To Launch Safety Syringe In Mid-2010
This article was originally published in The Gray Sheet
Revolutions Medical is seeking up to $1.5 million in additional financing to manufacture and commercialize its flagship Rev Vac safety syringe, according to CEO Ron Wheet
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.